Cognition Therapeutics (CGTX) Stock Chart & Stock Price History $0.67 -0.01 (-2.06%) As of 12:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cognition Therapeutics Stock Price Performance The Cognition Therapeutics (CGTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 64.95%, with a year-to-date return of -3.04%. In the past month, the stock has increased 142.86%, reflecting recent market activity. As of the latest close, Cognition Therapeutics traded at $0.68 with a market cap of $42.16 million and volume of 5.16 million shares. Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+19.84%1 Month Performance+142.86%3 Month Performance+82.60%Year-To-Date Performance-3.04%1 Year Performance-64.95% CGTX Stock Chart for Friday, July, 18, 2025 CGTX Chart by TradingView Cognition Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$0.62$0.68+10.28%$0.69$0.635.16 million shs$42.16 million07/16/2025$0.57$0.62+8.56%$0.67$0.5918.59 million shs$38.22 million07/15/2025$0.61$0.57-6.12%$0.61$0.554.05 million shs$35.21 million07/14/2025$0.57$0.61+6.63%$0.65$0.574.99 million shs$37.51 million07/11/2025$0.70$0.57-19.06%$0.66$0.569.10 million shs$35.18 million07/10/2025$0.53$0.70+31.69%$1.04$0.65244.68 million shs$43.46 million07/09/2025$0.59$0.53-9.55%$0.64$0.524.85 million shs$33.00 million07/08/2025$0.58$0.59+1.68%$0.63$0.527.95 million shs$36.48 million07/07/2025$0.45$0.58+27.49%$0.61$0.4342.12 million shs$35.88 million07/04/2025$0.45$0.45$0.42$0.3514.39 million shs$28.15 million Get the Latest News and Ratings for CGTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$0.34$0.45+35.44%$0.42$0.3514.39 million shs$28.14 million07/02/2025$0.31$0.34+7.33%$0.35$0.321.61 million shs$20.78 million07/01/2025$0.31$0.31+0.81%$0.31$0.291.43 million shs$19.36 million06/30/2025$0.30$0.31+3.27%$0.33$0.30643,119 shs$19.21 million06/27/2025$0.32$0.30-7.55%$0.34$0.301.24 million shs$18.60 million06/26/2025$0.30$0.32+8.17%$0.33$0.301.01 million shs$20.12 million06/25/2025$0.30$0.30$0.33$0.302.32 million shs$18.60 million06/24/2025$0.26$0.30+15.61%$0.31$0.271.52 million shs$18.60 million06/23/2025$0.26$0.26+1.76%$0.28$0.25932,185 shs$16.09 million06/20/2025$0.28$0.26-8.93%$0.29$0.26904,035 shs$15.81 million06/19/2025$0.28$0.28$0.30$0.28795,197 shs$17.36 million06/18/2025$0.28$0.28$0.30$0.28795,197 shs$17.36 million06/17/2025$0.32$0.28-13.04%$0.32$0.281.03 million shs$17.36 million Related Companies Contineum Therapeutics Stock Chart Coya Therapeutics Stock Chart Tenaya Therapeutics Stock Chart IO Biotech Stock Chart Vaxart Stock Chart OptiNose Stock Chart Cassava Sciences Stock Chart XBiotech Stock Chart Corbus Pharmaceuticals Stock Chart OKYO Pharma Stock Chart Receive CGTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cognition Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CGTX) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredNew crypto laws coming. Will you win or lose?Washington’s first-ever “Crypto Week” could trigger a major Bitcoin surge — but one trader says don’t just buy...Brownstone Research | SponsoredI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | Sponsored"I'm risking my reputation on this"Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the sa...Crypto 101 Media | SponsoredWill I be blacklisted?Porter Stansberry says a financial force bigger than 9/11 or COVID is already ripping through America — and mo...Porter & Company | Sponsored“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CGTX Stock Alerts